Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

Velligan, Dawn I, Sajatovic, Martha, Hatch, Ainslie, Kramata, Pavel, Docherty, John·2017·Patient Preference and Adherence
DOI 10.2147/ppa.s124658

Cited by (332)

Items 101–200 of 332

  1. Patient Compliance: Fact or Fiction?
    Abdul Kader Mohiuddin · 2019 · INNOVATIONS in pharmacy · Retracted
  2. The Patient’s Role in Patient Safety
    Ilene Corina, Marissa D. Abram, David Halperin · 2019 · Obstetrics and Gynecology Clinics of North America
  3. Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
    Ita Fitzgerald, Sarah O'Dwyer, Margaret Brooks, Laura Jane Sahm, Erin K. Crowley, Ciara Ní Dhubhlaing · 2021 · Frontiers in Psychiatry
  4. Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa
    Krishanand R. Roopun, Andrew M. Tomita, Saeeda Paruk · 2020 · South African Journal of Psychiatry
  5. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first‐episode psychosis
    Ana Catalán, Lorena García, Sergio Sánchez-Alonso, Patxi Gil, Marina Díaz‐Marsá, José Manuel Olivares, Tania Rivera Baltanás, Jorge Pérez‐Martín, Miguel Ángel González Torres, Santiago Ovejero et al. · 2020 · Early Intervention in Psychiatry
  6. Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction
    Claudio Brasso, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni, Marco Giuseppe Alberto Nobili, Rodolfo Sgro, Paola Rocca · 2023 · Journal of Clinical Medicine
  7. Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data
    Rashmi Patel, Aimee Brinn, Jessica Irving, Jaya Chaturvedi, S. Gudiseva, Christoph Ulrich Correll, Paolo Fusar‐Poli, Philip K. McGuire · 2023 · Therapeutic Advances in Psychopharmacology
  8. Family psychoeducation in schizophrenia and schizophrenia related disorder, treatment compliance, and suicidal risk reduction: questions about their relationship from a naturalistic observation
    Yann Hodé, Romain Padovani, Wydad Hikmat, Nathalie Guillard-Bouhet, Jérôme Attal, Marie‐Cécile Bralet, Mélanie Biotteau, Isabelle Chéreau, Olivier Canceil, Aurélie Montagne Larmurier et al. · 2024 · Frontiers in Psychiatry
  9. Deprescribing antipsychotics in patients with schizophrenia: findings from a specialized clinic
    Alexander Nøstdal, Rikke W. Hilker, Christina Halgren, Helene Speyer, Mette Ødegaard Nielsen, Jimmi Nielsen · 2024 · Psychological Medicine
  10. The Effect of Cognitive Behavioural Therapy–Based Psychoeducation on Medication Adherence and Aggression in Individuals Diagnosed With Schizophrenia: An Experimental Study
    Sevinç Yaşar Can, Funda Kavak Budak · 2024 · Journal of Psychiatric and Mental Health Nursing
  11. Optimising prescribing for patients with severe mental illness: the need for criteria
    Aoife Carolan, Dolores Keating, Judith Strawbridge, Cristín A. Ryan · 2019 · Evidence-Based Mental Health
  12. Specialized inpatient treatment for young people with early psychosis: acute-treatment and 12-month results
    Stefan Siebert, Karolina Leopold, Johanna Baumgardt, Laura von Hardenberg, Eva Burkhardt, Andreas Bechdolf · 2022 · European Archives of Psychiatry and Clinical Neuroscience
  13. Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience
    French Housing First Study Group, Aurélie Tinland, K. Zemmour, Pascal Auquier, Mohamed Boucékine, Vincent Girard, Sandrine Loubière, Guillaume B. Fond, Laurent Boyer · 2017 · Social Psychiatry and Psychiatric Epidemiology
  14. Attitudes to Medication—Treatment Among Patients and Caregivers
    Nidhi Chauhan, Subho Chakrabarti, Sandeep Grover · 2019 · Journal of Clinical Psychopharmacology
  15. Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics
    Carlos De las Cuevas, José de León · 2020 · Patient Preference and Adherence
  16. Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs
    Stefano Bramante, Gabriele Di Salvo, Giuseppe Maina, Gianluca Rosso · 2023 · Neuropsychiatric Disease and Treatment
  17. Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting
    Rabab M. Ibrahim, Mahmoud H. M. Teaima, Mohamed A. El-Nabarawi, Noha M. Badawi · 2024 · Journal of Drug Delivery Science and Technology
  18. Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia
    Christopher Zacker, Justin T. Puckett, Sachin J. Kamal‐Bahl · 2024 · ClinicoEconomics and Outcomes Research
  19. Medication Adherence and Drug Attitude Amongst Male Patients with the Methamphetamine-Induced Psychotic Disorder After Discharge: A Three Months Follow Up Study
    Marzieh Asadi, Vahid Rashedi, Nooshin Khademoreza, Ruohollah Seddigh, Amir‐Abbas Keshavarz‐Akhlaghi, Hamidreza Ahmadkhaniha, Seied-Mohamadhosein Rezvaniardestani, Ali Lotfi, Mohammadreza Shalbafan · 2021 · Journal of Psychoactive Drugs
  20. Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental Illness
    Felicia M. Forma, Teresa Green, Seung Kim, Christie L. Teigland · 2020 · ClinicoEconomics and Outcomes Research
  21. A national study of the mental health literacy of community pharmacists
    Retina Rimal, Joanne C. Lin, Amy Hai Yan Chan, Timothy Frank Chen, Janie L. Sheridan, Frederick Sundram · 2022 · Research in Social and Administrative Pharmacy
  22. Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study
    Andrea Aguglia, Laura Fusar‐Poli, Antimo Natale, Andrea Amerio, Irene Espa, Veronica Villa, Giovanni Martinotti, Giuseppe Carrà, Francesco Bartoli, Armando D’Agostino et al. · 2022 · Pharmacopsychiatry
  23. Patients’ perception of coercion with respect to antipsychotic treatment of psychotic disorders and its predictors
    Hirsch, Sophie, Thilo, Nancy, Steinert, Tilman, Flammer, Erich · 2021 · Social Psychiatry and Psychiatric Epidemiology
  24. Evaluation of the Relationship between Disability and Disease Severity, Cognitive Functions, and Insight in Patients with Schizophrenia
    Hatice Ayça Kaloğlu, Şerif Bora Nazlı · 2024 · Clinical Psychopharmacology and Neuroscience
  25. Treatment adherence to psychotropic drugs among non-Western migrants: a systematic review
    Maria Sacha, Hinuga Sandahl, Line Harck, Jessica Mariana Carlsson · 2021 · Nordic Journal of Psychiatry
  26. Modeling Health Disparities and Outcomes in Disenfranchised Populations
    Emily Jean Hauenstein, Rachael S. Clark, Elizabeth Merwin · 2018 · Community Mental Health Journal
  27. Health‐related Internet use and treatment adherence: A transdiagnostic comparison of outpatients with major depressive disorder and schizophrenia
    Maxim Zavorotnyy, Frank Ehrlich, Igor Nenadić · 2020 · PsyCh Journal
  28. The development and validation of a medicines optimisation tool to protect the physical health of people with severe mental illness (OPTIMISE)
    Aoife Carolan, Dolores Keating, Stephen McWilliams, Caroline Hynes-Ryan, Mary O’Neill, Fiona Boland, Sharon Holland, Judith Strawbridge, Cristín A. Ryan · 2022 · BMC Psychiatry
  29. Lack of Insight in Bipolar Disorder: The Impact on Treatment Adherence, Adverse Clinical Outcomes and Quality of Life
    Cătălina Angela Crișan · 2018 · InTech eBooks
  30. The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
    Andrea Aguglia, Laura Fusar‐Poli, Andrea Amerio, Valeria Placenti, Carmen Concerto, Giovanni Martinotti, Giuseppe Carrà, Francesco Bartoli, Armando D’Agostino, Gianluca Serafini et al. · 2021 · Frontiers in Psychiatry
  31. Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study
    Akitoyo Hishimoto, Norio Yasui‐Furukori, Daisuke Sekine, Miyuki Matsukawa, Sakiko Yamada · 2022 · Advances in Therapy
  32. ‘Precision’ or ‘personalized’ psychiatry: different terms – same content?
    Giampaolo Perna, Francesco Cuniberti, Silvia Daccò, Massimiliano Grassi, Daniela Caldirola · 2020 · Fortschritte der Neurologie · Psychiatrie
  33. Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study
    Dulcinea Vega, Francisco J. Acosta, Pedro Saavedra · 2020 · World Journal of Psychiatry
  34. Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study
    Venla Lehti, Heidi T. Taipale, Mika Gissler, Antti J. Tanskanen, Martta Elonheimo, Jari Tiihonen, Jaana Suvisaari · 2021 · Psychological Medicine
  35. Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
    Jesper Østrup Rasmussen, Poul Jennum, Kristían Línnet, Birte Yding Glenthoj, Lone Baandrup · 2021 · BMC Psychiatry
  36. One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients’, Relatives’, and Mental Health Professionals’ Perspectives
    S Kor Spoelstra, Jojanneke Bruins, Leonie Bais, Paul Seerden, Stynke Castelein, Henderikus Knegtering · 2022 · Patient Preference and Adherence
  37. One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients’, Relatives’, and Mental Health Professionals’ Perspectives
    Symen Kornelis Spoelstra, Jojanneke Bruins, Leonie Bais, Paul Seerden, Stynke Castelein, Henderikus Knegtering · 2022 · Dove Medical Press (Taylor and Francis Group)
  38. Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies
    Sun Lee, Shaina E. Schwartz · 2021 · Psychiatry Research
  39. Behind the Gaps: A Narrative Review of Healthcare Barriers for Individuals with Serious Mental Illness
    Courtney N. Wiesepape, Sarah E. Queller Soza, Laura A. Faith · 2025 · Healthcare
  40. Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency ward
    Claudio Brasso, Marta Cisotto, Camilla Ghirardini, Filippo Pennazio, Vincenzo Villari, Paola Rocca · 2021 · Psychiatry Research
  41. Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia
    Leslie Citrome, Christoph Ulrich Correll, Andrew J. Cutler, Martin Dunbar, Amber R Hoberg, Craig Hopkinson, Gregory W. Mattingly, James A McGrory, Bhaskar Rege, Peter J. Weiden et al. · 2025 · Neuropsychiatric Disease and Treatment
  42. Insight's level in borderline personality disorder, questioning consciousness
    Sylvia S. Martin, Pierluigi Graziani, Jonathan Del-Monte · 2020 · Journal of Affective Disorders Reports
  43. Alcohol use in Tanzanians with chronic psychotic disorders and poor medication adherence
    Emily Simon, Jennifer B. Levin, Jessie Kazeni Kilonzo Mbwambo, Carol E. Blixen, Isaac Lema, Michelle E. Aebi, Godwin Njiro, Kristin A. Cassidy, Sylvia Kaaya, Martha Sajatovic · 2021 · South African Journal of Psychiatry
  44. The influence of psychosocial factors on the intention to incorporate complementary and integrative medicine into psychiatric clinical practices
    Corinne Schaub, Catherine Bigoni, Quentin Baumeler, Mohamed Faouzi, Kétia Alexandre · 2021 · Complementary Therapies in Clinical Practice
  45. Impact of nurse‐led medication adherence therapy on bipolar affective disorder: A randomized controlled trial
    Shreedevi I. Balikai, Sreevani Rentala, Irasangappa Basavaraj Mudakavi, Raghavendra Bheemappa Nayak · 2022 · Perspectives In Psychiatric Care
  46. Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study
    Julia Spaton Goppers, Ellenor Mittendorfer‐Rutz, Alexis E. Cullen, Christopher Jamil de Montgomery, Antti J. Tanskanen, Marie Louise Nørredam, Heidi T. Taipale · 2023 · BJPsych Open
  47. Severity Of Relapse And Medication Adherence In Patient Of Schizophrenia: A Study From Nepal
    Pranisha Singh, Srijana Karmacharya, S. Khadka · 2019 · Journal of Psychiatrists Association of Nepal
  48. 10 devastating consequences of psychotic relapses
    Henry A. Nasrallah · 2021 · Current Psychiatry
  49. Point-of-care companion diagnostic tests for personalizing psychiatric medications: fulfilling an unmet clinical need
    Anil S. Modak · 2017 · Journal of Breath Research
  50. Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction
    Alexander Nøstdal, Rikke W. Hilker, Jimmi Nielsen, Mette Ødegaard Nielsen · 2024 · Psychiatric Services
  51. Anosognosia in Schizophrenia
    Benjamin Rose, Philip D. Harvey · 2024 · Cambridge University Press eBooks
  52. Poor insight and self-disorders in schizophrenia: an empirical study
    Lars Siersbæk Nilsson, Julie Nordgaard, Mads Gram Henriksen, Josef Parnas, Andreas Rosén Rasmussen · 2025 · European Archives of Psychiatry and Clinical Neuroscience
  53. Informing the development of a decision aid: Expectations and wishes from service users and psychiatrists towards a decision aid for antipsychotics in the inpatient setting
    Katharina Müller, Florian Schuster, Silvia Krumm, Stefan Leucht, Spyridon Siafis, Stephan Heres, Peter Brieger, Johannes Hamann · 2023 · Health Expectations
  54. The lived experience of Omani adolescents and young adults with mental illness: A qualitative study
    Omar Al Omari, Gerald Amandu Matua, Samir Al‐Adawi, Zubaida Shebani, Ibtisam Al Harthy, Arwa Atef Obeidat, Khloud Al Dameery, Mohammad Ibrahim Al Qadire, Iman Al Hashmi, Abduallh Al Khawldeh et al. · 2023 · PLoS ONE
  55. Mental Health Needs, Substance Use, and Reincarceration: Population-Level Findings From a Released Prison Cohort
    Amanda Butler, Tonia L. Nicholls, Hasina Samji, Sheri Fabian, Miriam Ruth Lavergne · 2024 · Criminal Justice and Behavior
  56. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder
    Mary F. Brunette, Robert M. Roth, Christi L. Trask, Jibran Younis Khokhar, James Ford, Soo Hwan Park, Sara M. Hickey, Thomas A. Zeffiro, Haiyi Xie · 2024 · Schizophrenia Bulletin
  57. A Review of Factors Relating to Medication Non-Adherence in Patients with Schizophrenia
    Soontareeporn Meepring, Phatcharapon Tulyakul, Ghunyanutt Sathagathonthun, Jaruwan Suppasri · 2021 · Global Journal of Health Science
  58. Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia
    Kristen M. Ward, Leslie Citrome · 2024 · Expert Opinion on Drug Safety
  59. Adherence to neuroleptic treatment in psychiatric practices: A retrospective study of 55 practices with more than 5000 bipolar and schizophrenic patients in Germany
    Jens Bohlken, Marcel Konrad, Karel Kostev · 2020 · Psychiatry Research
  60. The Waiving of Parole Consideration by Inmates With Mental Illness and Recidivism Outcomes
    Jason C. Matejkowski, Michael Ostermann · 2020 · Criminal Justice and Behavior
  61. Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data
    Erica L. Stockbridge, Nathaniel J. Webb, Eleena Dhakal, Manasa Garg, Abiah D. Loethen, Thaddeus L. Miller, Karabi Nandy · 2021 · BMC Health Services Research
  62. Risk factors and strategies for relapse prevention among individuals living with serious mental illness in South Africa: Qualitative inquiry from patients’ and caregivers’ perspectives
    Joyce Protas Mlay, Thirusha Naidu, Suvira Ramlall, Sbusisiwe Sandra Mhlungu, Makhosazane Zondi, Richard J. Lessells, Jennifer I. Manuel, Andrew M. Tomita · 2024 · PLoS ONE
  63. Insight and Violence: An Overview of the Possible Link and Treatment Options in Forensic Psychiatric Settings
    Bianca Malina Horgoș, Daniel Ungureanu, Cătălina‐Angela Crișan · 2024 · Psychiatry International
  64. Medication non-adherence in re-admitted patients at a psychiatry hospital: A qualitative study
    Gopolang E. Zwide, Zukiswa T. Dewet, Funeka B. Sokudela · 2025 · South African Journal of Psychiatry
  65. Psychosocial and Demographic Factors Associated with Physical Multimorbidity in Severe Mental Illness: A Systematic Review
    Erin G Lawrence, Uzma Zahid, Abigail C Thomson, Robin S. Lau, Laura Havers, Federica Biotti, Monica Acosta Pereira, Mark C. Freestone, Irene González-Calvo, Brent Elliott et al. · 2025 · Schizophrenia Bulletin
  66. UHPLC-MS/MS for Antipsychotic Drug Monitoring: A Systematic Review of Clinical and Analytical Performance
    Ciprian Ionut Bacila, Bianca-Maria Macavei, Monica Cornea, Bogdan Ioan Vintilă, Andrei Lomnășan, Claudia Elena Anghel, Andreea Maria Grama, Cristina Elena Dobre, Claudia Marina Ichim, Gabriela Cioca · 2025 · Journal of Clinical Medicine
  67. Why using “consciousness” in psychotherapy? Insight, metacognition and self-consciousness
    Sylvia S. Martin · 2023 · New Ideas in Psychology
  68. Physical and sexual victimization of persons with severe mental illness seeking care in central and southwestern Uganda
    Richard Stephen Mpango, Wilber Joseph Ssembajjwe, Godfrey Zari Rukundo, Philip Amanyire, Carol Birungi, Allan Kalungi, Rwamahe Rutakumwa, Christine Tusiime, Kenneth D. Gadow, Vikram Patel et al. · 2023 · Frontiers in Public Health
  69. Characterization of activity behavior using a digital medicine system and comparison to medication ingestion in patients with serious mental illness
    Jeffrey M. Cochran, Zahra Heidary, Jonathan Knights · 2021 · npj Digital Medicine
  70. Impact of treatment-related discussions on healthcare resource use and costs among patients with severe mental illness
    Felicia M. Forma, Eleena Koep, John C. White, Angela Belland, Heidi C. Waters, Carolyn K. Martin · 2021 · Current Medical Research and Opinion
  71. Factors Associated with Adherence to Follow-up Among Patients with Depressive Disorders in a Collaborative Care Program in Iran
    Atefeh Mohammadjafari, Maryam Tabatabaee, Vandad Sharifi‎, Fattaneh Abdi Masouleh, Farid Abolhassani · 2021 · Iranian Journal of Psychiatry and Behavioral Sciences
  72. Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?
    Samer El Hayek, Malek Shatila, Jana A. Adnan, Luna Geagea, Firas H. Kobeissy, Farid Ramzi Talih · 2022 · Expert Review of Neurotherapeutics
  73. Examining clinician choice to follow-up (or not) on automated notifications of medication non-adherence by clinical decision support systems
    Dan Thorpe, Jörg E. Strobel, Niranjan P. Bidargaddi · 2023 · BMC Medical Informatics and Decision Making
  74. Relationship Between Insight, Adherence and Disability in the Diagnose of Paranoid Schizophrenia
    Ignacio García Cabeza · 2018 · JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY
  75. Discrepancies between Self- and Clinical Staff Members’ Perception of Cognitive Functioning among Patients with Schizophrenia Undergoing Long-Term Hospitalization
    Fumiko Kaneko, Hitoshi Okamura · 2019 · Occupational Therapy International
  76. Client Outreach in Los Angeles County’s Assisted Outpatient Treatment Program: Strategies and Barriers to Engagement
    Sarah Linsley Starks, Erin Lee Kelly, Enrico G. Castillo, Marcia L. Meldrum, Philippe I. Bourgois, Joel Tupper Braslow · 2020 · Research on Social Work Practice
  77. Predição da adesão ao tratamento e qualidade de vida de pacientes com transtorno bipolar
    Clarice De Lourdes Enes, Pedro Henrique Batista de Freitas, Sebastião Júnior Henrique Duarte, Marco Túlio Resende Clementino, Aline Esteves Pacheco, Richardson Miranda Machado · 2020 · Revista de Enfermagem do Centro-Oeste Mineiro
  78. Thinking inside the box
    Jeroen Deenik · 2019
  79. Medication beliefs and adherence to antipsychotic medication in patients diagnosed with schizophrenia: The moderating role of doctor–patient communication
    Godwin Ocansey, Enoch Teye‐Kwadjo, Joseph Osafo · 2024 · International Journal of Mental Health
  80. Factors shaping the decision-making process to continue or discontinue antipsychotics: exploratory qualitative study of 12 individuals in remission from first-episode psychosis
    Laurent Béchard, Elizabeth Anderson, Olivier Corbeil, Maxime Huot‐Lavoie, Sébastien Brodeur, Amal Abdel‐Baki, Charles Massé, Mina Gabriel-Courval, Marie-Ève Coté, Annie LeBlanc et al. · 2025 · BJPsych Open
  81. A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs
    Johanna Seifert, R. Grohmann, Sermin Toto, Matthias A. Reinhard, Stefan Bleich, Andreas Erfurth, Cornelius Schüle, Susanne Stübner, Catherine Glocker · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  82. Assessing the impact of long‐acting injectable compared to oral antipsychotic medications on readmission to a state psychiatric hospital
    Chizimuzo T.C. Okoli, Bassema Abufarsakh, Tianyi Wang, A Makowski, Andrew Cooley · 2024 · Journal of Psychiatric and Mental Health Nursing
  83. Bringing Personalized Medicine to a PACT Program: A Quality Improvement Project
    Virginia M. Conley, Sandra Daack‐Hirsch, Katie Halbmaier, Lisa Shaw · 2019 · Journal of the American Psychiatric Nurses Association
  84. A higher degree of insight impairment in stabilized schizophrenia patients is associated with reduced cardiac vagal tone as indexed by resting-state high-frequency heart rate variability
    Chin-Chao Ma, Yu‐Chen Kao, Nian‐Sheng Tzeng, Che-Yi Chao, Chuan-Chia Chang, Hsin‐An Chang · 2020 · Asian Journal of Psychiatry
  85. Antipsychotic Medications: Enhancing Use to Improve Outcomes
    Hiroyoshi Takeuchi, Stefan Leucht, John Michael Kane, Ofer Agid, Gary J. Remington · 2021 · Schizophrenia Bulletin
  86. Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia: Practical Considerations
    Karan S. Kverno, Ilya Rozenberg · 2021 · Journal of Psychosocial Nursing and Mental Health Services
  87. Examining the association of alcohol use and psychotropic medication adherence among women with severe mental illness in South Africa
    Lihle Mgweba-Bewana, Jennifer M. Belus, Jonathan Ipser, Jessica F. Magidson, John A. Joska · 2021 · Psychiatry Research
  88. Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
    Nina Vadiei, Jasim El-Ali, Joss Delaune, Cecilia Wild, Yi‐Shao Liu · 2022 · Exploratory Research in Clinical and Social Pharmacy
  89. Barrieren bei der Implementierung pharmakogenetischer Testungen in der Psychiatrie in Deutschland – Ergebnisse aus der FACT-PGx Studie
    Martina Hahn, Amelie Merle Frantz, Andreas Philipp Eckert, Andreas Reif · 2023 · Fortschritte der Neurologie · Psychiatrie
  90. Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia
    Yusuke Iwata, Yu Aruga, Masataka Ohtsuki, Masahiro Inoue, Kazuyuki Yasuda, Takashi Hirata, Takuji Uemura, Takefumi Suzuki · 2021 · Journal of Clinical Psychopharmacology
  91. Sex and age effects on prevalence of CYP2C19 and CYP2D6 Phenoconversion risk over time in patients with psychosis
    Emma Y De Brabander, Nicole K. Leibold, Thérèse van Amelsvoort, Roos van Westrhenen, Behrooz Z. Alizadeh, Wiepke Cahn, Lieuwe de Haan, Marieke van der Pluijm, Claudia J.P. Simons, Jim van Os et al. · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  92. Assessing treatment adherence in psychiatry: a comparison of clinical judgment and therapeutic drug monitoring in acute care
    Giorgio Pigato, Nicola Meda, Marco Paladin, Tommaso Toffanin, Carlo Artusi, Fabio Sambataro · 2025 · International Clinical Psychopharmacology
  93. Effect of Nurse-Led Screening Linked Brief Psycho-education for Improving Adherence to Antipsychotic Medications among Clients with Mental Illness
    Hemlata Ghatwal, Jaison Joseph, Purushottam Jangid · 2021 · Journal of Mental Health and Human Behaviour
  94. Adherence to Medication in Psychiatric Disorders
    Yumi Aoki, Hiroyoshi Takeuchi, Koichiro Watanabe, Allan Tasman · 2023 · Springer eBooks
  95. Cost‐Sharing Increase, Medication Adherence, and Hospitalizations in Schizophrenia Patients: A Natural Experiment
    Miquel Serra‐Burriel, Isabel Hurtado, Gabriel Sanfélix‐Gimeno, Aníbal García‐Sempere, Salvador Peiró · 2021 · Clinical Pharmacology & Therapeutics
  96. A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue
    Raakhi Tripathi, Sharmila Vinayak Jalgaonkar, Snehalata Vijayanand Gajbhiye, Nishtha Khatri, Mohsin Sayyed, Shubhangi Parkar · 2021 · Indian Journal of Psychological Medicine
  97. Une approche de la psychopharmacologie des premiers épisodes psychotiques axée sur le rétablissement
    Laurent Béchard, Olivier Corbeil, Esthel Malenfant, Catherine Lehoux, Émmanuel Stip, Marc‐André Roy, Marie‐France Demers · 2021 · Santé mentale au Québec
  98. Relapse among MHCUs after a Short-Term Admission in an Acute Psychiatric Unit: Primary Caregivers’ Perspective
    Nelson Raluthaga, Hilda Nwamuhohova Shilubane, Mygirl Pearl Lowane · 2023 · International Journal of Environmental Research and Public Health
  99. Knowledge of the treatment in schizophrenia and schizoaffective disorder and its relationship with nonadherence.
    Francisco J. Acosta, Dulcinea Vega, Pedro Saavedra · 2023 · Actas Españolas de Psiquiatría
  100. Adherence of patients with schizophrenia to hypothyroidism treatment
    Shay Gur, Shira Weizman, Haggai Hermesh, Andre Matalon, Joseph Meyerovitch, Amir Krivoy · 2023 · Cambridge Prisms Global Mental Health